Logo image of ALINT.PA

INTEGRAGEN (ALINT.PA) Stock Price, Quote, News and Overview

EPA:ALINT - Euronext Paris - Matif - FR0010908723 - Common Stock - Currency: EUR

0.522  0 (0%)

ALINT.PA Quote, Performance and Key Statistics

INTEGRAGEN

EPA:ALINT (6/6/2025, 7:00:00 PM)

0.522

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High0.86
52 Week Low0.43
Market Cap3.51M
Shares6.73M
Float2.18M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO06-18 2010-06-18


ALINT.PA short term performance overview.The bars show the price performance of ALINT.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 -10 -15

ALINT.PA long term performance overview.The bars show the price performance of ALINT.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40 -50

The current stock price of ALINT.PA is 0.522 EUR. In the past month the price decreased by -14.41%. In the past year, price decreased by -13%.

INTEGRAGEN / ALINT Daily stock chart

ALINT.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 18.51 294.28B
AMG.DE AMGEN INC 14.03 137.20B
1AMGN.MI AMGEN INC 13.85 135.48B
GIS.DE GILEAD SCIENCES INC 14.44 121.78B
1GILD.MI GILEAD SCIENCES INC 14.14 119.24B
VX1.DE VERTEX PHARMACEUTICALS INC N/A 100.95B
ARGX.BR ARGENX SE 110.06 31.52B
22UA.DE BIONTECH SE-ADR N/A 23.13B
IDP.DE BIOGEN INC 8.4 17.06B
0QF.DE MODERNA INC N/A 9.20B
1MRNA.MI MODERNA INC N/A 9.10B
BIO.DE BIOTEST AG N/A 1.67B

About ALINT.PA

Company Profile

ALINT logo image IntegraGen SA engages in the development of genetic biomarkers. The company is headquartered in Evry, Ile-De-France. The company went IPO on 2010-06-18. The company researches and develops biomarkers for use as diagnostic tools in the fields of autism, oncology, diabetes and obesity. The company uses an evaluation model with several autism-related genes using a combination of several common polymorphisms (Single-Nucleotide Polymorphism or SNP or common variant). The company also develops molecular biomarker validation programs for Hepatocellular Carcinoma and anti-epidermal growth factor receptor (anti-EGFR) resistance markers. The firm also provides genomics services to practitioners and researchers, such as DNA extraction, marker selection and tagging and bioinformatical analysis of sequence data in such fields as pharmacogenetics, cytogenetics, epigenetics, search for mutations and SNP discovery, among others. As of December 31, 2011, the Company operated through a wholly owned subsidiary, IntegraGen Inc.

Company Info

INTEGRAGEN

Genopole Campus 1 - Genavenir 8 5 Rue Henri Desbrueres

Evry ILE-DE-FRANCE FR

Employees: 44

ALINT Company Website

ALINT Investor Relations

Phone: 33160910900

INTEGRAGEN / ALINT.PA FAQ

What is the stock price of INTEGRAGEN today?

The current stock price of ALINT.PA is 0.522 EUR.


What is the ticker symbol for INTEGRAGEN stock?

The exchange symbol of INTEGRAGEN is ALINT and it is listed on the Euronext Paris - Matif exchange.


On which exchange is ALINT.PA stock listed?

ALINT.PA stock is listed on the Euronext Paris - Matif exchange.


What is INTEGRAGEN worth?

INTEGRAGEN (ALINT.PA) has a market capitalization of 3.51M EUR. This makes ALINT.PA a Nano Cap stock.


How many employees does INTEGRAGEN have?

INTEGRAGEN (ALINT.PA) currently has 44 employees.


What are the support and resistance levels for INTEGRAGEN (ALINT.PA) stock?

INTEGRAGEN (ALINT.PA) has a support level at 0.52 and a resistance level at 0.65. Check the full technical report for a detailed analysis of ALINT.PA support and resistance levels.


Should I buy INTEGRAGEN (ALINT.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INTEGRAGEN (ALINT.PA) stock pay dividends?

ALINT.PA does not pay a dividend.


What is the Price/Earnings (PE) ratio of INTEGRAGEN (ALINT.PA)?

INTEGRAGEN (ALINT.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).


ALINT.PA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

ALINT.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ALINT.PA. The financial health of ALINT.PA is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALINT.PA Financial Highlights

Over the last trailing twelve months ALINT.PA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 50% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -0.48%
ROE -1.58%
Debt/Equity 0.22
Chartmill High Growth Momentum
EPS Q2Q%50%
Sales Q2Q%-24.96%
EPS 1Y (TTM)50%
Revenue 1Y (TTM)-11.77%

ALINT.PA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 87% to ALINT.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
Analysts
Analysts86.67
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A